XML 90 R79.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Subsequent Events (Details) - HRA Pharma Rare Diseases Business
€ in Millions, $ in Millions
3 Months Ended
Jun. 30, 2024
USD ($)
Sep. 30, 2024
EUR (€)
Mar. 30, 2024
USD ($)
Subsequent Event [Line Items]      
Assets to be disposed of, excluding cash     $ 325.6
Liabilities to be disposed of     $ 57.2
Forecast      
Subsequent Event [Line Items]      
Total consideration | €   € 275  
Upfront cash payment | €   190  
Potential earnout payments | €   € 85  
Forecast | Minimum      
Subsequent Event [Line Items]      
Impairment loss $ 20.0    
Forecast | Maximum      
Subsequent Event [Line Items]      
Impairment loss $ 30.0